BMJ Case Reports 2012; doi:10.1136/bcr-02-2012-5802
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum

  1. Charles Chan2
  1. 1School of Clinical Medicine, University of Cambridge, Cambridge, UK
  2. 2Gleneagles Medical Centre, Singapore, Singapore
  1. Correspondence to Charleen Min Li Chan Wah Hak, charleen.chan{at}


A patient with long-standing immune thrombocytopenic purpura (ITP) would logically contradict antiplatelet use due to increased bleeding risk during coronary stenting. Coronary stenting using an endothelial progenitor cells (EPC) capture stents (GenousTM) was used to successfully revascularise our patient using a transradial approach. The only complication was extensive superficial ecchymosis on the patient's forearm from antiplatelet use, which resolved spontaneously. To the best of our knowledge, this is the first case report of EPC capture stents in a chronic ITP patient.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article